Demographics (2)
- age - Subject age (phv00389874.v1.p1)
- sex - Gender of subject (phv00389872.v1.p1)
Race and Ethnicity (1)
- race - Race of subject (phv00389873.v1.p1)
Substance Use (1)
- tobacco_use - Subject tobacco use (phv00389875.v1.p1)
Other (20)
- AFFECTION_STATUS - Case control status of the subject for lung cancer (phv00389867.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00389881.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00389880.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00389866.v1.p1)
- days_to_death - Number of days between diagnosis date and death date (phv00389877.v1.p1)
- days_to_last_followup - Number of days between diagnosis date and last follow-up date (phv00389876.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00389887.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00389883.v1.p1)
- IS_TUMOR - Tumor status (phv00389882.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00389884.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00389879.v1.p1)
- SAMPLE_ID - Sample ID (phv00389869.v1.p1)
- SAMPLE_USE - Sample Use (phv00389870.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00389888.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00389871.v1.p1)
- SUBJECT_ID - Subject ID (phv00389865.v1.p1)
- SUBJECT_ID - Subject ID (phv00389868.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00389886.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00389885.v1.p1)
- vital_status - Vital status (phv00389878.v1.p1)